[{"Assets_0_Q2_USD":126040000.0,"CommonStockSharesOutstanding_0_Q2_shares":34193666.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-27523000.0,"NetIncomeLoss_1_Q2_USD":-18036000.0,"NetIncomeLoss_2_Q2_USD":-33970000.0,"StockholdersEquity_0_Q2_USD":108382000.0,"Ticker":"YMAB","CIK":"1722964","name":"Y-MABS THERAPEUTICS, INC.","OfficialName":"Y-mAbs Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"556910423.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190814"}]